Entropy and information content of laboratory test results

American Journal of Clinical Pathology

Volumn 127, Issue 1, 2007, Pages 60-65

  Vollmer, Robin T ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Cervical cytology; Entropy; HER 2 neu; Information; Laboratory tests; Melanoma; Probability; Prostate specific antigen; Statistics; Troponin I; Tumor thickness

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROSTATE SPECIFIC ANTIGEN; TROPONIN I;

ARTICLE; CYTOLOGY; DISEASE MARKER; ENTROPY; LABORATORY TEST; MEDICAL INFORMATION; MELANOMA; PRIORITY JOURNAL; CLINICAL CHEMISTRY; FEMALE; HUMAN; INFORMATION SCIENCE; PATHOLOGY; PROBABILITY; STANDARD; UTERINE CERVIX; VALIDATION STUDY;

CERVIX UTERI; CLINICAL CHEMISTRY TESTS; ENTROPY; FEMALE; HUMANS; INFORMATION THEORY; MELANOMA; PROBABILITY; PROSTATE-SPECIFIC ANTIGEN; RECEPTOR, ERBB-2; TROPONIN I;

EID: 34248999475     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/H1F0WQW44F157XDU     Document Type: Article

References (22)

1. Shannon CE, Weaver W. The Mathematical Theory of Communication. Urbana, IL: University of Illinois Press; 1949.
2. Giasu S. Information Theory With Applications. New York, NY: McGraw-Hill; 1977.
3. Adams JE, Schechtman KB, Landt Y, et al. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem. 1994;40:1291-1295.
4. Zaninotto M, Altinier S, Lachin M, et al. Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction. Clin Chem. 1996;42:1460-1466.
5. D'Costa M, Fleming E, Patterson M. Cardiac troponin I for the diagnosis of acute myocardial infarction in the emergency department. Am J Clin Pathol. 1997;108:550-555.
6. Apple FS, Koplen B, Murakami MM. Preliminary evaluation of the Vitros ECi cardiac troponin I assay. Clin Chem. 2000;46:572-574.
7. Apple FS, Quist HE, Doyle PJ, et al. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with the European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem. 2003;49:1331-1336.
8. Grunkemeier MN, Vollmer RT. Predicting prostate biopsy results: the importance of PSA, age, and race. Am J Clin Pathol. 2006;126:110-112.
9. Hoang MP, Sahin AA, Ordonez NG, et al. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol. 2000;113:852-859.
10. Wang S, Saboorian MH, Frenkel EP, et al. Assessment of HER-2/neu status in breast cancer: Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochernical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol. 2001;116:495-503.
11. McCormick SR, Lillemoe TJ, Beneke J, et al. HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization. Am J Clin Pathol. 2002;117:935-943.
12. Bofin AM, Yttherhus B, Martin C, et al. Detection and quantification of HER-2 gene amplification and protein expression in breast cancer. Am J Clin Pathol. 2004;122:110-119.
13. Lai P, Tan LK, Chen B. Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast cancers. Am J Clin Pathol. 2005;123:541-546.
14. de Cremoux P, Coste J, Sastre-Garau X, et al. Efficiency of the Hybrid Capture 2 HPV DNA test in cervical cancer screening. Am J Clin Pathol. 2003;120:492-499.
15. Schiller CL, Nickolov AG, Kaul DL, et al. High-risk human papillomavirus detection: a split-sample comparison of Hybrid Capture and chromogenic in situ hybridization. Am J Clin Pathol. 2004;121:537-545.
16. Castle PE, Wheeler CM, Solomon D, et al. Interlaboratory reliability of Hybrid Capture 2. Am J Clin Pathol. 2004;122:238-245.
17. Kendall BS, Bush AC, Olsen CH, et al. Reflex high-risk human papillomavirus testing for women with atypical squamous cells of undetermined significance in cytologic smears: effects since implementation in a large clinical practice. Am J Clin Pathol. 2005;123:524-528.
18. Stadelmann WK, Rapaport DP, Soong S-J, et al. Prognostic factors that influence melanoma outcome. In: Balch CM, Houghton AN, Sober AJ, et al, eds. Cutaneous Melanoma. 3rd ed. St Louis, MO: Quality Medical Publishing; 1998:11-35.
19. Vollmer RT. Predictive probability of serum prostate specific antigen for prostate cancer: an approach using Bayes rule. Am J Clin Pathol. 2006;125:336-342.
20. Rudolph RA, Bernstein LH, Babb J. Information induction for predicting acute myocardial infarction. Clin Chem. 1988;34:2031-2038.
21. Bernstein LH, Rudolph RA, Pinto MM, et al. Medically significant concentrations of prostate-specific antigen in serum assessed. Clin Chem. 1990;36:515-518.
22. Pinto MM, Bernstein LH, Rudolph RA, et al. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions. Arch Pathol Lab Med. 1992;116:626-631.